A Pilot Study Assessing EmSam in Bipolar Depression

Summary

This pilot study will evaluate the efficacy of the monoamine oxidase inhibitor (MAOI)EmSam, a selegiline transdermal system (STS), in bipolar depression.

Timeline

Start

2007-03

Primary completion

2012-02

Completion

2012-02

Outcome

Outcome not reported

Stopped: “Current lack of medication support.”

Drugs

Indications